Abstract
Tumor necrosis factor (TNF) plays an important role in the pathogenesis of rheumatoid arthritis (RA). Different genetic variants including the TNF −308G/A polymorphism are associated with RA susceptibility. However, these findings have not been replicated in all populations. The aim of this study was to determine whether the TNF −1031T/C (rs1799964), −376G/A (rs1800750), −308G/A (rs1800629) −238G/A (rs361525), and TNFR1 −609G/T polymorphisms are associated with RA susceptibility in a sample of Mexican patients. Our study included 499 patients with RA and 492 healthy controls. The genotypes of the TNF polymorphisms were obtained using TaqMan assay. The genotype and allele frequencies of the TNF −1031T/C, −376G/A, −308G/A, −238G/A, and TNFR1 −609G/T polymorphisms were similar among RA cases versus healthy controls, and no association with RA susceptibility was identified. Our results suggest that the TNF −1031T/C, −376G/A, −308G/A, −238G/A, and TNFR1 −609G/T polymorphisms are not associated with RA susceptibility in a sample of Mexican patients.
Similar content being viewed by others
References
Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916
Fragoso JM, Vargas-Alarcón G, Jiménez-Morales S, Reyes-Hernández OD, Ramírez-Bello J (2014) Tumor necrosis factor alpha (TNF-α) in autoimmune diseases (AIDs): molecular biology and genetics. Gac Med Mex 150:334–344
Kaijzel EL, Bayley JP, van Krugten MV, Smith L, van de Linde P, Bakker AM et al (2001) Allele-specific quantification of tumor necrosis factor a (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immun 2:135–144
Rodríguez-Elías AK, Maldonado-Murillo K, López-Mendoza LF, Ramírez-Bello J (2016) Genetics and genomics in rheumatoid arthritis (RA): an update. Gac Med Mex 152:218–227
Keystone EC, Genovese MC, Klareskog L, Hsia EC, Hall ST, Miranda PC et al (2009) Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis 68:789–796
Fischer R, Kontermann RE, Maier O (2015) Targeting sTNF/TNFR1 signaling as a new therapeutic strategy. Antibodies 4:48–70
Roux-Lombard P, Punzi L, Hasler F, Bas S, Todesco S, Gallati H, Guerne PA, Dayer JM (1993) Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 36:485–489
Dieudé P, Osorio J, Petit-Teixeira E, Moreno S, Garnier S, Cailleau-Moindrault S et al (2004) A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 50:413–419
Ramírez-Bello J, Vargas-Alarcón G, Tovilla-Zárate C, Fragoso JM (2013) Single nucleotide polymorphisms (SNPs): functional implications of regulatory-SNP (rSNP) and structural RNA (srSNPs) in complex diseases. Gac Med Mex 149:220–228
El-Tahan RR, Ghoneim AM, El-Mashad N (2016) TNF‑α gene polymorphisms and expression. Springerplus 5:1508
Waldron-Lynch F, Adams C, Amos C, Zhu DK, McDermott MF, Shanahan F, Molloy MG, O’Gara F (2001) Tumour necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2:82–87
Li F, Gao J, Sokolove J, Xu J, Zheng J, Zhu K, Pan Z (2014) Polymorphisms in the TNF-a, TNFR1 gene and risk of rheumatoid arthritis in Chinese Han population. Int J Immunogenet 41:499–502
Mosaad YM, Abdelsalam A, El-Bassiony SR (2011) Association of tumour necrosis factor-alpha – 308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis. Int J Immunogenet 38:427–433
Lagha A, Zidi S, Stayoussef M, Gazouani E, Kochkar R, Kochbati S, Almawi WY, Yacoubi-Loueslati B (2015) Interleukin-1b, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-a polymorphisms in Tunisian patients with rheumatoid arthritis. Pathol Biol 63:179–184
Boechat AL, Boechat Nde O, Ogusku MM, Alencar MR, Abensur Tda C, Cardoso Neto J et al (2013) The influence of a TNF gene polymorphism on the severity of rheumatoid arthritis in the Brazilian Amazon. Cytokine 61:406–412
Rodríguez-Carreón AA, Zúñiga J, Hernández-Pacheco G, Rodríguez-Pérez JM, Pérez-Hernández N et al (2005) Tumor necrosis factor-alpha – 308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun 24:63–68
Nemec P, Pavkova-Goldbergova M, Stouracova M, Vasku A, Soucek M, Gatterova J (2008) Polymorphism in the tumor necrosis factor-α gene promoter is associated with severity of rheumatoid arthritis in the Czech population. Clin Rheumatol 27:59–65
Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A (2008) Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol 27:1243–1248
Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S (2010) Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol Int 30:1211–1217
Rezaieyazdi Z, Afshari JT, Sandooghi M, Mohajer F (2007) Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 28:189–191
Lacki JK, Moser R, Korczowska I, Mackiewicz S, Muller W (2000) TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int 19:137–140
Lee YH, Bae SC (2015) Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: a meta-analysis. Genet Mol Res 14:5548–5559
Mousa AK, Ghoneim AM, Noha B, Ahmed E (2014) TNF-α genetic polymorphisms and its expression in Egyptian rheumatoid arthritis patients. Am J Life Sci 2:234–240
Fakhfakh Karray E, Bendhifallah I, BenAbdelghani K, Hamzaoui K, Zakraoui L (2011) Tumor necrosis factor gene polymorphisms and susceptibility to rheumatoid arthritis in regional Tunisian population. J Infect Dis Immun 3:30–35
Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 5′ flanking region of the human TNF a gene in Japanese. Tissue Antigens 51:605–612
Miterski B, Drynda S, Böschow G, Klein W, Oppermann J, Kekow J, Epplen JT (2004) Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet 5:2
López-Cano DJ, Cadena-Sandoval D, Beltrán-Ramírez O, Barbosa-Cobos RE, Sánchez-Muñoz F, Amezcua-Guerra LM et al (2017) The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves’ disease in a Mexican population. Inflamm Res 66:775–781
Ramírez-Bello J, Jiménez-Morales S, Espinosa-Rosales F, Gómez-Vera J, Gutiérrez A, Velázquez-Cruz R, Baca V, Orozco L (2013) Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol 53:374–378
Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149–160
Song GG, Bae SC, Kim JH, Lee YH (2014) Association between TNF‑α promoter – 308 A/G polymorphism and rheumatoid arthritis: a meta‑analysis. Rheumatol Int 34:465–471
Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219–224
Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G et al (2009) Tumor necrosis factor-α is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol 70:251–256
Mendoza-Rincón JF, Rodríguez-Elias AK, Fragoso JM, Vargas-Alarcón G, Maldonado-Murillo K, Rivas-Jiménez ML et al (2016) MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients. Rheumatol Int 36:249–254
Chen R, Fang M, Cai Q, Duan S, Lv K, Cheng N et al (2007) Tumor necrosis factor alpha – 308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China. Rheumatol Int 28:121–126
Hussein YM, Mohamed RH, Pasha HF, El-Shahawy EE, Alzahrani SS (2011) Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients. Cell Immunol 271:192–196
Seki N, Kamizono S, Yamada A, Higuchi T, Matsumoto H, Niiya F et al (1999) Polymorphisms in the 5′-flanking region of tumor necrosis factor-a gene in patients with rheumatoid arthritis. Tissue Antigens 54:194–197
Funding
This study was funded by a grant of the Consejo Nacional de Ciencia y Tecnología de México (CONACyT) (FOSISS; project no. 233107).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No author has received research grants, except the corresponding author, who received the grant from the Consejo Nacional de Ciencia y Tecnología de México. The authors declare no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Cadena-Sandoval, D., Alemán-Ávila, I., Barbosa-Cobos, R.E. et al. Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population. Mol Biol Rep 45, 227–232 (2018). https://doi.org/10.1007/s11033-018-4155-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-018-4155-2